Dongxing Medical announced that the company plans to jointly invest in the establishment of Changzhou Lingnao Intelligent Technology Co., Ltd. with Guoxing Investment controlled by the controlling shareholder and actual controller Wan Shiping. The target company has a registered capital of 30 million yuan, of which the company plans to invest 20 million yuan with its own capital, accounting for 66.67%; Guoxing Investment will invest 10 million yuan, accounting for 33.33%. This transaction constitutes a related transaction and does not constitute a major asset restructuring. After the investment is completed, the target company will be included in the scope of the company's consolidated statements and become a holding subsidiary of the company. This investment is the company's strategic initiative to lay out the brain-computer interface medical field and extend the industrial chain. It is currently in the preparation stage. Shareholder agreements have not yet been signed, industrial and commercial registration has not been completed, and there is uncertainty about implementation.

Zhitongcaijing · 1d ago
Dongxing Medical announced that the company plans to jointly invest in the establishment of Changzhou Lingnao Intelligent Technology Co., Ltd. with Guoxing Investment controlled by the controlling shareholder and actual controller Wan Shiping. The target company has a registered capital of 30 million yuan, of which the company plans to invest 20 million yuan with its own capital, accounting for 66.67%; Guoxing Investment will invest 10 million yuan, accounting for 33.33%. This transaction constitutes a related transaction and does not constitute a major asset restructuring. After the investment is completed, the target company will be included in the scope of the company's consolidated statements and become a holding subsidiary of the company. This investment is the company's strategic initiative to lay out the brain-computer interface medical field and extend the industrial chain. It is currently in the preparation stage. Shareholder agreements have not yet been signed, industrial and commercial registration has not been completed, and there is uncertainty about implementation.